Primary Mammary Angiosarcoma in a Postmenopausal Woman: A Case Report
Cancer Reports, Volume 9, Issue 9, September 2026.ABSTRACT Background Primary breast angiosarcoma (PAS) is a rare aggressive mesenchymal breast tumor, which predominantly affects young premenopausal women and is prone to misdiagnosis due to nonspecific clinical and imaging features. Surgical resection is the main treatment, while the efficacy of adjuvant chemoradiotherapy remains unclear.
Tingting Liu +8 more
wiley +1 more source
VEGFR-1 inE. coliBBB infection
, 2013 The key aspect of neonatal meningitis is related to the ability of pathogens to invade the blood-brain barrier (BBB) and to penetrate the central nervous system. In the present study we show that, in an in vitro model of BBB, on the basis of co-culturing primary bovine brain endothelial cells (BBEC) and primary bovine retinal pericytes (BRPC ...
Mario Alberghina +7 more
openaire +1 more source
Cancer Reports, Volume 9, Issue 9, September 2026.ABSTRACT Background N4‐acetylcytidine (ac4C) RNA modification has emerged as a critical epigenetic regulator in tumorigenesis and progression. However, the comprehensive landscape of ac4C modification in colorectal cancer (CRC), particularly its orchestration of the tumor microenvironment (TME) and stromal crosstalk, remains largely unexplored.
Yang Xia +3 more
wiley +1 more source
Knockdown of RPL28 Inhibits the Progression of Clear Cell Renal Cell Carcinoma
Cancer Reports, Volume 9, Issue 9, September 2026.ABSTRACT Background Clear cell renal cell carcinoma (ccRCC) is the most common and aggressive histological subtype of kidney cancer. Previous studies have implicated ribosomal protein L28 (RPL28) in the progression of various cancers; however, its role in ccRCC remains unclear.
Runbiao Luo +5 more
wiley +1 more source
Correction: Vascular endothelial growth factor receptor-1 (VEGFR-1) knock-down is protective against hypoxia, Aβ1-42 oligomer and Aβ1-42 fibril-induced neuronal cell death: implications in AD pathogenesis. [PDF]
Front NeurosciAngom RS +10 more
europepmc +1 more source
Weichang'an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer-Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1. [PDF]
Front Pharmacol, 2020 Pan CF +5 more
europepmc +1 more source
Cancer‐related pain: A bidirectional modulator of cancer progression
Clinical and Translational Medicine, Volume 16, Issue 9, September 2026.CRP and tumour progression engage in a dynamic, bidirectional circuit mediated by multiple mechanisms involving neuroimmunology and cancer ‐neuroscience. Analgesic interventions may affect tumour progression, while anticancer therapies can influence pain. Targeting pain in cancer may have promising therapeutic value in cancer progression.
Junzhe He +5 more
wiley +1 more source
Role of VEGFs/VEGFR-1 Signaling and its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models. [PDF]
Int J Mol Sci, 2020 Ceci C, Atzori MG, Lacal PM, Graziani G.
europepmc +1 more source
Immunolocalization of VEGF, VEGFR-1 and VEGFR-2 in lung tissues after acute hemorrhage in rats
In treatment of hypovolemia it is important to reestablish normal tissue hemodynamics after fluid resuscitation. Vascular endothelial growth factor (VEGF) and VEGF receptors (VEGFR) have been identified as important in many physiological and pathological,
Ekerbicer, N +3 more
core